Stage-Specific Plasma Metabolomic Profiles in Colorectal Cancer
Authors:
Open Access
- 2 September 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5202
Abstract
Background/Objectives: The objective of this study was to investigate the metabolomic profiles of patients with colorectal cancer (CRC) across various stages of the disease. Methods: The plasma samples were obtained from 255 subjects, including patients with CRC in stages I-IV, polyps, and controls. We employed capillary electrophoresis time-of-flight mass spectrometry and liquid chromatography triple quadrupole mass spectrometry to analyze hydrophilic metabolites comprehensively. The data were randomly divided into two groups, and consistent differences observed in both groups were analyzed. Results: Acetylated polyamines, such as N1-acetylspermine and N1, N12-diacetylspermine, consistently showed elevated concentrations in stage IV compared to stages I-III. Non-acetylated polyamines, including spermine and spermidine, exhibited increasing trends from polyp to stage IV. Other metabolites, such as histidine and o-acetylcarnitine, showed decreasing trends across stages. While acetylated polyamines have been reported as CRC detection markers, our findings suggest that they also possess diagnostic potential for distinguishing stage IV from other stages. Conclusions: This study showed stage-specific changes in metabolic profiles, including polyamines, of colorectal cancer.Keywords
Funding Information
- JSPS KAKENHI (JP22K08857)
This publication has 48 references indexed in Scilit:
- Biomarker discovery and validation for gastrointestinal tumors: A comprehensive review of colorectal, gastric, and liver cancersPathology - Research and Practice, 2024
- Exosomal non-coding RNAs: Blueprint in colorectal cancer metastasis and therapeutic targetsNon-coding RNA Research, 2023
- Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal CancerJAMA Oncology, 2019
- Metabolomics Platform with Capillary Electrophoresis Coupled with High-Resolution Mass Spectrometry for Plasma AnalysisAnalytical Chemistry, 2018
- Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trialThe Lancet Oncology, 2015
- Effects of processing and storage conditions on charged metabolomic profiles in bloodElectrophoresis, 2015
- Evaluating the utility of N1,N12-diacetylspermine and N1,N8-diacetylspermidine in urine as tumor markers for breast and colorectal cancersClinica Chimica Acta, 2010
- Differential metabolomics software for capillary electrophoresis-mass spectrometry data analysisMetabolomics, 2009
- Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profilesMetabolomics, 2009
- Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and gradeInternational Journal of Colorectal Disease, 2002